文献速递妇产影像儿科影像心血管US

母亲糖尿病对胎儿超声心动图心脏功能的影响:系统综述与荟萃分析

Effect of maternal diabetes on fetal heart function on echocardiography: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-01-01

该系统综述与荟萃分析检索EMBASE、PubMed和Cochrane图书馆至2019年7月4日,纳入39项研究(2276例对照、1925例糖尿病孕妇),评估产前超声心动图测量的胎儿心脏功能。结果显示母亲糖尿病与胎儿心脏肥厚、舒张功能不全及整体心肌功能受损相关,无论糖尿病为孕前还是妊娠期;孕早期即可出现,孕晚期最显著。

要点

  • 糖尿病孕妇胎儿心脏肥厚在21/26项研究中更常见,舒张功能不全在22/28项研究中观察到。
  • 孕晚期荟萃分析显示孕前糖尿病和妊娠期糖尿病胎儿室间隔厚度均较对照增加。
  • 收缩功能关联不一致,但测量心肌形变(应变)的较新研究显示糖尿病孕妇胎儿收缩功能减低。

关键影像表现/征象

  • 胎儿心脏肥厚在糖尿病孕妇中更常见(21/26项研究)。
  • 舒张功能不全在糖尿病孕妇中观察到(22/28项研究)。
  • 收缩功能关联不一致,10/25项研究报告病例与对照无差异,但测量心肌形变(应变)的较新研究显示糖尿病孕妇胎儿收缩功能减低。
  • 整体胎儿心脏功能:多数研究(14/21)发现糖尿病孕妇显著受损。
  • 这些效应在孕早期即已存在,但在孕晚期最显著。

诊断标准与关键数值

  • 孕晚期孕前糖尿病胎儿室间隔厚度平均差0.75 mm(95%CI 0.56-0.94 mm),妊娠期糖尿病平均差0.65 mm(95%CI 0.39-0.91 mm),均较对照增加。
  • 孕晚期孕前糖尿病胎儿E/A比值平均差-0.09(95%CI -0.15至-0.03),较对照降低;妊娠期糖尿病E/A比值平均差-0.01(95%CI -0.02至0.01),与对照无差异。
  • 孕晚期孕前糖尿病胎儿心肌性能指数平均差0.04(95%CI -0.01至0.09),妊娠期糖尿病平均差0.03(95%CI -0.01至0.06),均与对照无差异。

临床应用与阅片要点

  • 产前超声评估胎儿心脏时,对糖尿病孕妇应注意室间隔增厚、E/A比值降低及整体心肌性能受损等征象。
  • 收缩功能评估中,常规参数可能无差异,测量心肌形变(应变)的较新研究显示收缩功能减低。
  • 这些效应在孕早期即可出现,孕晚期最显著,提示随访中动态评估。

局限性

  • 需进一步研究以证明与长期结局的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Maternal diabetes in pregnancy is associated with structural anomalies of the fetal heart, as well as hypertrophy and functional impairment. This systematic review and meta-analysis aimed to estimate the effect of maternal diabetes on fetal cardiac function as measured by prenatal echocardiography.

METHODS: We performed a search of the EMBASE, PubMed and The Cochrane Library databases, from inception to 4 July 2019, for studies evaluating fetal cardiac function using echocardiography in pregnancies affected by diabetes compared with uncomplicated pregnancies. Outcome measures were cardiac hypertrophy and diastolic, systolic and overall cardiac function as assessed by various ultrasound parameters. The quality of the studies was assessed using the Newcastle-Ottawa Scale. Data on interventricular septal (IVS) thickness, myocardial performance index (MPI) and E/A ratio were pooled for the meta-analysis using random-effects models. For pregnancies with diabetes, results were reported overall and according to whether diabetes was pregestational (PDM) or gestational (GDM). Results were also stratified according to the trimester in which fetal cardiac assessment was performed.

RESULTS: Thirty-nine studies were included, comprising data for 2276 controls and 1925 women with pregnancy affected by diabetes mellitus (DM). Of these, 1120 had GDM, 671 had PDM and in 134 cases diabetes type was not specified. Fetal cardiac hypertrophy was more prevalent in diabetic pregnancies than in non-diabetic controls in 21/26 studies, and impaired diastolic function was observed in diabetic pregnancies in 22/28 studies. The association between DM and systolic function was inconsistent, with 10/25 studies reporting no difference between cases and controls, although more recent studies measuring cardiac deformation, i.e. strain, did show decreased systolic function in diabetic pregnancies. Of the studies measuring overall fetal cardiac function, the majority (14/21) found significant impairment in diabetic pregnancies. Results were similar when stratified according to GDM or PDM. These effects were already present in the first trimester, but were most profound in the third trimester. Meta-analysis of studies performed in the third trimester showed, compared with controls, increased IVS thickness in both PDM (mean difference, 0.75 mm (95% CI, 0.56-0.94 mm)) and GDM (mean difference, 0.65 mm (95% CI, 0.39-0.91 mm)) pregnancies, decreased E/A ratio in PDM pregnancies (mean difference, -0.09 (95% CI, -0.15 to -0.03)), no difference in E/A ratio in GDM pregnancies (mean difference, -0.01 (95% CI, -0.02 to 0.01)) and no difference in MPI in either PDM (mean difference, 0.04 (95% CI, -0.01 to 0.09)) or GDM (mean difference, 0.03 (95% CI, -0.01 to 0.06)) pregnancies.

CONCLUSIONS: The findings of this review show that maternal diabetes is associated with fetal cardiac hypertrophy, diastolic dysfunction and overall impaired myocardial performance on prenatal ultrasound, irrespective of whether diabetes is pregestational or gestational. Further studies are needed to demonstrate the relationship with long-term outcomes. © 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Depla AL, De Wit L, Steenhuis TJ, et al. Effect of maternal diabetes on fetal heart function on echocardiography: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021. PMID: 32730637. doi:10.1002/uog.22163

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。